Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Informatics|July 29, 2016
Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery StrategiesDaniel Blasi, Gemma Arsequell, Gregori Valencia, et al.Journal of Medicinal Chemistry|January 10, 2012
Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive propertiesMònica Rosa, Gemma Arsequell, Catherine Rougeot, et al.Journal of Medicinal Chemistry|October 24, 2013
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenationEllen Y Cotrina, Marta Pinto, Lluís Bosch, et al.Annals of Surgical Oncology|July 19, 2013
miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinomaJ M Hernandez, A Elahi, C W Clark, et al.Journal of Medicinal Chemistry|January 6, 2006
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptorAngelo Carotti, Maria Isabel Cadavid, Nuria B Centeno, et al.Bioorganic & Medicinal Chemistry|January 30, 2008
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptorAngela Stefanachi, Jose Manuel Brea, Maria Isabel Cadavid, et al.Journal of Medicinal Chemistry|January 5, 2002
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanonesJosé Brea, Jordi Rodrigo, Antonio Carrieri, et al.Plos One|January 7, 2009
Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitorsTeresa Mairal, Joan Nieto, Marta Pinto, et al.Pageof 3